In short
- There is a loop. High insulin raises androgens, and the androgens make the metabolic picture worse.
- That is why the usual advice fails. Eat less and move more ignores the mechanism doing the work against you.
- Modest loss is enough to matter. Many women resume more regular cycles after a small weight loss.
- The metabolic risk is real. Metabolic syndrome affects roughly a third to a half of women with PCOS, and fatty liver about 43 percent.
- Insulin testing is not routine. It does not predict who responds, so it is used only where it changes a decision.
Condition Overview
Polycystic ovary syndrome is a hormonal condition characterised by irregular ovulation, signs of raised androgens and, in many patients, polycystic ovarian appearance on ultrasound. Insulin resistance is present in a large proportion of cases, independent of weight, and it is the main reason weight gain is common and weight loss unusually difficult.
Typical presentations include central weight gain, irregular or absent periods, acne, excess hair growth and scalp hair thinning. A private consultation is appropriate for the metabolic component because it is measurable and treatable, and treating it often improves both weight and cycle regularity. Diagnosis and gynaecological or fertility management remain with the appropriate specialist. The metabolic treatment overlaps with insulin resistance.
Cost & Program Investment
When to See a Doctor
- You have a PCOS diagnosis and your weight has increased despite reasonable eating and activity.
- You have irregular periods together with central weight gain and want the metabolic side investigated.
- You have been told you have insulin resistance or borderline blood sugar alongside PCOS.
- You have a family history of type 2 diabetes, which raises your own risk considerably with this condition.
- You want one physician managing the metabolic treatment while your gynaecologist manages the rest.
- You are trying to conceive or are pregnant, in which case weight medication is not used and care is coordinated with your specialist.
- You have very rapid onset of excess hair growth, voice deepening or severe symptoms, which need endocrine assessment for another cause before anything else.
How Dr. Felix Assesses This
-
1
Goals and history
Your PCOS history and how it was diagnosed, cycle pattern, current gynaecological care, whether pregnancy is planned, your weight history, family history of diabetes, and every medicine including hormonal contraception.
-
2
Medical review
Examination, blood pressure, waist measurement and body composition, with blood work covering fasting glucose, HbA1c, fasting insulin where appropriate, lipids, liver, kidney and thyroid function, and hormone testing coordinated with your specialist.
-
3
Suitability decision
Dr. Felix explains how much of your weight problem is metabolically driven, which findings need treatment, what is realistic to expect, and which questions belong with your gynaecologist or endocrinologist rather than with him.
-
4
Personal plan
A written plan focused on insulin sensitivity: protein and carbohydrate structure, resistance training, sleep, treatment of any finding, a clear position on medication given your pregnancy plans, and dated retesting.
Treatment Options
Metabolic Weight Loss Program
What does metabolic mean here? It means the biochemistry that decides how your body stores and releases energy, rather than…
View Treatment
Medical Weight Loss Program
Why has the weight not moved? Most patients who come here have already tried hard, more than once, and lost…
View Treatment
Physician-Supervised Weight Management
Where weight programmes actually fail Almost never in week one. The four common points are predictable, and each has an…
View Treatment
Why Early Treatment Can Matter
Insulin sensitivity is the part of PCOS that responds most reliably to treatment, and improving it often does more than weight loss alone. Resistance training and adequate protein change glucose handling directly, and modest waist reduction can improve cycle regularity for some patients.
PCOS also carries a raised long term risk of type 2 diabetes, which is worth monitoring from the start rather than discovering later. Nothing here is urgent. It simply means an early metabolic assessment gives you a baseline and a plan while the numbers are still favourable.
Why Early Treatment Can Matter
Insulin sensitivity is the part of PCOS that responds most reliably to treatment, and improving it often does more than weight loss alone. Resistance training and adequate protein change glucose handling directly, and modest waist reduction can improve cycle regularity for some patients.
PCOS also carries a raised long term risk of type 2 diabetes, which is worth monitoring from the start rather than discovering later. Nothing here is urgent. It simply means an early metabolic assessment gives you a baseline and a plan while the numbers are still favourable.
Metabolism responds well
Improving insulin sensitivity often helps weight and cycle regularity together.
Long term diabetes risk
PCOS carries raised risk of type 2 diabetes, worth monitoring from the outset.
A measured baseline
Early testing means changes are tracked against your own numbers over time.
Cost & Consultation Investment
The assessment is laboratory led because the metabolic picture has to be measured rather than assumed, and it takes account of testing your gynaecologist may already have done. What follows depends on the findings, whether medication is appropriate given your plans, and how closely the results are followed. Current figures are on the pricing page.
Frequently Asked Questions
Because insulin resistance is common regardless of your weight. High insulin promotes fat storage around the middle and blocks fat release, and it also raises androgens, which makes the picture worse. That is a mechanism, not a motivation problem.
High insulin acts directly on the ovary to increase androgen production and lowers sex hormone binding globulin in the liver, so more testosterone circulates in its active form. That is why acne, hair growth and cycle disruption often track with the metabolic picture.
Routine insulin testing is not recommended. It cannot separate how much resistance comes from PCOS and how much from body weight, and its size does not predict who responds to treatment. Glucose, HbA1c, lipids and liver values guide management instead.
Often less than expected. Many women with PCOS and excess weight resume more regular cycles after a modest loss. It is not guaranteed, and it is not a fertility treatment, but the threshold is much lower than most people assume.
Not necessarily. The core features are irregular or absent ovulation and raised androgens. Polycystic looking ovaries alone are not sufficient for the diagnosis, and plenty of women have them without the syndrome.
Yes. Insulin resistance in PCOS occurs independently of weight, which is why the metabolic work up matters even when your body mass index looks fine.
Metabolic syndrome affects roughly a third to a half of women with PCOS, about twice the rate of age matched women, and fatty liver is found in around 43 percent. That is why blood pressure, lipids and glucose are treated on their own merits.
No. Fertility, ovulation induction, contraception decisions and gynaecological care belong with a specialist and you will be referred. What is handled here is the metabolic side and the weight.
It is one option among several, and the decision is individual. Where obesity is the dominant problem a weight medicine may be more logical. Neither replaces resistance training and the structural work.
Then this becomes an obstetric and fertility question first. PCOS carries higher rates of gestational diabetes, pregnancy induced hypertension, preeclampsia and preterm birth, so that care belongs with a specialist and weight medicines are stopped beforehand.
They respond more slowly than the metabolic values and often need treatment aimed at them specifically, which is usually a dermatology or gynaecology decision rather than something handled here.
It depends on the investigations you need and whether medication becomes part of the plan, so a single figure would be misleading. You get the full cost in the consultation before anything starts.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Obesity and overweightWorld Health Organization · Fact sheet
- Obesity: identification, assessment and managementNational Institute for Health and Care Excellence · Clinical guideline CG189
- Semaglutide for managing overweight and obesityNational Institute for Health and Care Excellence · Technology appraisal TA875, 2023
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)New England Journal of Medicine · Wilding JPH et al., 2021
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.